147 related articles for article (PubMed ID: 24480983)
21. Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough.
Hong JY; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
Korean J Intern Med; 2019 May; 34(3):559-568. PubMed ID: 30540903
[TBL] [Abstract][Full Text] [Related]
22. Eosinophilic airway disorders associated with chronic cough.
Niimi A; Matsumoto H; Mishima M
Pulm Pharmacol Ther; 2009 Apr; 22(2):114-20. PubMed ID: 19121405
[TBL] [Abstract][Full Text] [Related]
23. Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial.
Silverman M; Sheffer AL; Díaz PV; Lindberg B
Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():14-20. PubMed ID: 16573704
[TBL] [Abstract][Full Text] [Related]
24. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
O'Connell EJ
Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
26. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
27. Caregiver treatment satisfaction is improved together with children's asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms.
Yoshihara S; Kanno N; Fukuda H; Arisaka O; Arita M; Sekine K; Yamaguchi K; Tsuchida A; Yamada Y; Watanabe T; Shimizu T; Nishikawa K; Nishimuta T
Allergol Int; 2015 Oct; 64(4):371-6. PubMed ID: 26433534
[TBL] [Abstract][Full Text] [Related]
28. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
29. Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?
Anderson WJ; Lipworth BJ
Ann Allergy Asthma Immunol; 2012 Apr; 108(4):237-42. PubMed ID: 22469442
[TBL] [Abstract][Full Text] [Related]
30. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma.
Stelmach I; Bobrowska-Korzeniowska M; Majak P; Stelmach W; Kuna P
Pulm Pharmacol Ther; 2005; 18(5):374-80. PubMed ID: 15939317
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
[TBL] [Abstract][Full Text] [Related]
32. Children with chronic cough: when is watchful waiting appropriate? development of likelihood ratios for assessing children with chronic cough.
Chang AB; Van Asperen PP; Glasgow N; Robertson CF; Mellis CM; Masters IB; Landau LI; Teoh L; Tjhung I; Petsky HL; Morris PS
Chest; 2015 Mar; 147(3):745-753. PubMed ID: 25501672
[TBL] [Abstract][Full Text] [Related]
33. Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma.
Tagaya E; Kondo M; Kirishi S; Kawagoe M; Kubota N; Tamaoki J
J Asthma; 2015 Jun; 52(5):512-8. PubMed ID: 25329681
[TBL] [Abstract][Full Text] [Related]
34. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
35. Comparison of improvement in quality of life score with objective parameters of pulmonary function in Indian asthmatic children receiving inhaled corticosteroid therapy.
Singh M; Mathew JL; Malhi P; Srinivas BR; Kumar L
Indian Pediatr; 2004 Nov; 41(11):1143-7. PubMed ID: 15591665
[TBL] [Abstract][Full Text] [Related]
36. Overall asthma control: the relationship between current control and future risk.
Bateman ED; Reddel HK; Eriksson G; Peterson S; Ostlund O; Sears MR; Jenkins C; Humbert M; Buhl R; Harrison TW; Quirce S; O'Byrne PM
J Allergy Clin Immunol; 2010 Mar; 125(3):600-8, 608.e1-608.e6. PubMed ID: 20153029
[TBL] [Abstract][Full Text] [Related]
37. Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma.
Zhang L; Prietsch SO; Mendes AP; Von Groll A; Rocha GP; Carrion L; Da Silva PE
Respirology; 2013 Feb; 18(2):272-7. PubMed ID: 23039314
[TBL] [Abstract][Full Text] [Related]
38. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
39. [Administration of budesonide (inhaled steroid) to children to control intermittent asthma].
Ponce Castro H; Rodríguez Espino S; Rodríguez Orozco AR
Rev Alerg Mex; 2009; 56(1):9-12. PubMed ID: 19374158
[TBL] [Abstract][Full Text] [Related]
40. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]